Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ionis gets $75M milestone in Bayer anticoagulant deal

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) is to receive a $75 million milestone payment from Bayer AG

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE